ArticleProceedings of the National Academy of Sciences of the United States of America2023

Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78.

Zhiwen Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.